https://www.selleckchem.com/pr....oducts/k-ras-g12c-in
Stenotrophomonas maltophilia causes high mortality infections in immunocompromised hosts with limited therapeutic options. Many U.S. laboratories rely on commercial automated antimicrobial susceptibility tests (cASTs) and use CLSI breakpoints (BPs) for S. maltophilia However, contemporary data on these systems is lacking. We assessed performances of Vitek2, MicroScan Walkaway and Phoenix relative to reference broth microdilution for trimethoprim-sulfamethoxazole (SXT), levofloxacin (LEV), minocycline (MIN) and ceftazidime
Like
Comment
Share
